NCT05991544

Brief Summary

It is aimed to prevent the development of oral mucositis or to reduce the severity of developing oral mucositis with the training to be given to patients receiving chemotherapy according to the Neuman systems model.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
94

participants targeted

Target at P50-P75 for not_applicable cancer

Timeline
Completed

Started Nov 2023

Shorter than P25 for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 6, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 14, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

November 1, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2024

Completed
Last Updated

January 31, 2024

Status Verified

January 1, 2024

Enrollment Period

2 months

First QC Date

August 6, 2023

Last Update Submit

January 30, 2024

Conditions

Keywords

nurseoral Mucositiseducation

Outcome Measures

Primary Outcomes (2)

  • Comfort Perception Scale in Oral Mucositis

    The scale was developed in 2019 by Erden and İpek Çoban to evaluate the perception of comfort in patients with oral mucositis. The scale consists of 31 items and 2 sub-dimensions.

    12 week

  • Oral Mucositis Grading Index:

    Developed by the World Health Organization and It is a staging scale. Grade 0: No symptoms. Grade 1: Pain or erythema. Grade 2: Painful, erythema, edema or ulcer present, but the patient can take solid foods. Grade 3: There is pain, erythema, edema or ulcer, the patient can only take liquid foods. Grade 4: No feeding.

    12 week

Study Arms (2)

Experimental

EXPERIMENTAL

Training and Follow-up According to the Neuman Systems Model

Behavioral: Training and Follow-up According to the Neuman Systems Model

Control

NO INTERVENTION

only procedure will be applied

Interventions

Neuman Systems Model (NSM) it presents a holistic approach to patients by including physiological, spiritual, sociocultural and five major developmental variables

Experimental

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Receiving chemotherapy treatment No mental or communication problems, Volunteering to participate in research. having internet, Having at least primary education level, Being able to use smart phone and internet. Being on treatment that causes methotrexate, Cispilatin, Cyclophoshamide, 5-fluorouracil group oral mucositis.

You may not qualify if:

  • lack of internet illiteracy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Atatürk university nursing faculty

Erzurum, Center, 25240, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

NeoplasmsStomatitis

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic Diseases

Study Officials

  • Gülcan B.TURAN

    Firat University

    PRINCIPAL INVESTIGATOR
  • Yasemin Erdem

    Erzurum Technical University

    PRINCIPAL INVESTIGATOR
  • Seda Karaman

    Atatatürk Üniversitesi

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gülcan B.TURAN

CONTACT

Yasemin Erdem

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 6, 2023

First Posted

August 14, 2023

Study Start

November 1, 2023

Primary Completion

January 1, 2024

Study Completion

July 1, 2024

Last Updated

January 31, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations